TP53 serves as a diagnostic and prognostic biomarker, the presence of TP53 mutations can serve as a diagnostic marker for AK and cSCC, as well as a prognostic indicator of disease progression and potential resistance to therapy (88). Here, TP53 is linked to skin squamous cell carcinoma.